サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363531

尿路結石管理装置の市場規模、シェア、動向分析レポート：治療タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年

Urolithiasis Management Devices Market Size, Share & Trends Analysis Report By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 115 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
尿路結石管理装置の市場規模、シェア、動向分析レポート：治療タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月27日
発行: Grand View Research
ページ情報: 英文 115 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

尿路結石管理装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の尿路結石管理装置市場は2030年までに22億1,000万米ドルと評価されました。

2023年から2030年までのCAGRは4.9%で拡大する見込みです。長年にわたる尿路結石の罹患率の憂慮すべき増加が、治療オプションの進歩の原因となっています。欧州泌尿器科学会は、尿路結石症は有病率10％の最も一般的な生活習慣病の一つであり、体系的な治療アプローチが必要であるとしています。

尿路結石症とは、主に腎臓、尿管、膀胱を含む泌尿器系に結石ができることを意味します。尿路結石症は、米国、カナダ、ドイツなどのハイエンド諸国における主要なヘルスケア問題であり、ほとんどの症例で50％の再発率を示しています。尿路結石症は、生活習慣の改善、食事管理、基本的な薬物療法によって管理することができます。しかし、激しい痛みを引き起こす大きな結石を除去するためには、さまざまな治療アプローチを採用する必要があります。結石の大きさ、体内の位置、尿生殖管の解剖学的変化に応じて、侵襲的または非侵襲的な結石除去方法があります。例えば、小さい結石は体外衝撃波（体外衝撃波結石破砕術）で、大きい結石は手術（体外衝撃波結石破砕術または経皮的腎結石摘出術）で取り除くことができます。

小さい結石は一般に外科的な介入を必要とせず、薬物療法と健康的な食事療法で治すことができます。しかし、結石が大きくなると、結石を除去するためにさまざまなアプローチが必要になります。体外結石破砕術は、結石除去のために採用される一般的な治療法の一つであり、2015年の市場シェアの大半を占めています。体腔内結石破砕術は、内視鏡の助けを借りて結石にスポットを当て、小さくする治療法です。結石の崩壊には、超音波またはレーザー技術が使用され、より小さな破片が尿路系を通過できるようにします。体腔内結石破砕術は無結石化率が高いため、予測期間中は治療の選択肢として好まれると思われます。

さらに、経皮的腎結石除去術は、体外または体内結石破砕術が効果がなく、通常1週間の入院が必要な場合に、より大きな結石を除去するために実施される外科的アプローチです。

外来手術センターは、従来の病院や診療所よりも時間とコストを節約できることから人気を集めています。その結果、この最終用途分野は予測期間中に有利な成長率が見込まれるとされています。短時間で効果的に尿路系から結石を排出するための、内視鏡やガイドワイヤー、メス、バスケットを含むマイクロアクセサリーなどの新しい手術技術のイントロダクションは、低侵襲手術の全体的な受容性を高めています。

尿路結石管理装置市場レポート・ハイライト

  • 尿路結石は世界的に非常に蔓延しており、世界の対象人口は15%、再発率は50%です。男性は女性よりも腎結石になりやすいです。
  • 体腔内結石破砕術セグメントが市場を独占し、2022年には34.6%の最大収益シェアを占め、予測期間には6.8%の最速CAGRで成長すると予測されます。体腔内結石破砕術は、内視鏡を使用して結石を可視化し、レーザーを使用して管理可能な断片に同時に分解します。
  • 先進諸国における不健康な食品消費の増加と相まって、座りがちなライフスタイルの採用が増加傾向にあることが、腎結石の発生率上昇の原因となっています。外来手術サービスプロバイダーは、特に先進国における不健康なライフスタイルの変化の結果として、治療需要の急増を経験すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 尿路結石管理装置市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 尿路結石管理装置市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 尿路結石管理装置：治療タイプの推定・動向分析

  • 尿路結石管理装置市場：重要なポイント
  • 尿路結石管理装置市場：動向と市場シェア分析、2022年および2030年
  • 体外衝撃波結石破砕術（ESWL）
    • 体外衝撃波結石破砕術
  • 体内砕石術
    • 体内結石破砕術市場推計・予測、2018年から2030年まで
  • 経皮的腎結石切開術
    • 経皮的腎結石切開術市場推計・予測、2018年から2030年まで
  • その他の治療法
    • その他の治療法市場推計・予測、2018年から2030年まで

第5章 尿路結石管理装置：最終使用推定・動向分析

  • 尿路結石管理装置市場：重要なポイント
  • 尿路結石管理装置市場：動向と市場シェア分析、2022年および2030年
  • 病院とクリニック
  • 外来手術センター（ASC）

第6章 尿路結石管理装置市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別の尿路結石管理装置市場：重要なポイント
  • 北米
    • 北米市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州市場推計・予測、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋市場推計・予測、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA市場推計・予測、2018年から2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Allengers
    • Boston Scientific
    • BD
    • Cook Medical
    • ConMed
    • DirexGroup
    • Dornier MedTech
    • Potent Optotronic
    • HealthTronics
    • Karl Storz
    • Lumenis
    • Olympus
    • Richard Wolf
    • Siemens Healthcare
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 3 North America urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 6 U.S. urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 8 Canada urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 10 Europe urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 13 Germany urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 15 UK urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 17 France urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 19 Italy urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 21 Spain urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 23 Sweden urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 25 Norway urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 27 Denmark urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 China urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 32 China urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 34 Japan urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 36 India urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 38 Australia urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 40 Thailand urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 42 South Korea urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 44 Latin America urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 47 Brazil urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 49 Mexico urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 51 Argentina urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 56 South Africa urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 UAE urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Urolithiasis management devices: Market outlook
  • Fig. 8 Urolithiasis management devices: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Urolithiasis management devices market driver impact
  • Fig. 14 Urolithiasis management devices market restraint impact
  • Fig. 15 Urolithiasis management devices market strategic initiatives analysis
  • Fig. 16 Urolithiasis management devices market: Treatment type movement analysis
  • Fig. 17 Urolithiasis management devices market: Treatment type outlook and key takeaways
  • Fig. 18 Extracorporeal shock wave lithotripsy (ESWL) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Intracorporeal lithotripsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Percutaneous nephrolithotomy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Other treatments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Urolithiasis management devices market: End use movement analysis
  • Fig. 23 Urolithiasis management devices market: End use outlook and key takeaways
  • Fig. 24 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global urolithiasis management devices market: Regional movement analysis
  • Fig. 27 Global urolithiasis management devices market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-152-8

Urolithiasis Management Devices Market Growth & Trends:

The global urolithiasis management devices market was valued at USD 2.21 billion by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 4.9% from 2023 to 2030. The alarming growth in the incidence rate of urinary stones, over the years, is responsible for the advancements in the treatment options. European Association of Urology states that it is one of the most common lifestyle disorders with a 10% prevalence rate and requires a systematic treatment approach.

Urolithiasis means formation of stones in the urinary system, mainly including the kidney, ureters, and the bladder. It is a major healthcare concern in the high end countries such as the U.S., Canada, and Germany with a recurrence rate of 50% in most of the cases. Urolithiasis can be managed with the help of lifestyle changes, controlled diet, or basic medication. However, various treatment approaches need to be adopted for the removal of large stones that cause severe pain. Depending upon the stone size, location in the body, and anatomical variations in the urogenital tract, invasive or noninvasive stone removal procedures are available. For instance, smaller stones can be tackled with external shock waves (extracorporeal shock wave lithotripsy), while larger stones can be removed through surgeries (intracorporeal lithotripsy or percutaneous nephrolithotomy).

Smaller stones generally do not require surgical interventions and can be cured with the help of medication and a healthy diet. However, larger stones necessitate different approaches for their elimination. Extracorporeal lithotripsy is one of the common treatments employed for stone elimination and held a majority market share in the year 2015. Intracorporeal lithotripsy treatments spot and reduce the stones to smaller pieces with the help of endoscopy. For the disintegration of stones, ultrasound or laser techniques are used to enable the passage of smaller fragments through the urinary system. Owing to the effective stone-free rate offered by intracorporeal lithotripsy, it is likely to be preferred as a treatment option during the forecast period.

Furthermore, percutaneous nephrolithotomy is a surgical approach deployed to eliminate larger stones where extracorporeal or intracorporeal lithotripsies prove to be ineffective and typically require a week's hospitalization.

Ambulatory surgical centers are gaining popularity over traditional hospital and clinic settings due to the time and cost saving benefits. As a result, this end-use segment is expected to record a lucrative growth rate during the forecast period. Introduction of novel surgical technologies, such as endoscopy and micro accessories including guidewires, scalpels, and baskets, to effectively expel stones from the urinary system in a short time has enhanced the overall acceptability of minimally invasive surgeries.

Urolithiasis Management Devices Market Report Highlights:

  • Urinary stones are highly prevalent worldwide with a 15% global target population and the recurrence rate of 50%. Men are more susceptible to developing renal stones than women.
  • The intracorporeal lithotripsy segment dominated the market and held the largest revenue share of 34.6% in 2022 and is expected to grow at the fastest CAGR of 6.8% over the forecast period. Intracorporeal lithotripsy involves the visualization of stones using an endoscope and their simultaneous disintegration into manageable fragments using lasers.
  • The upward trend in the adoption of sedentary lifestyle coupled with increased consumption of unhealthy food in the developed countries is responsible for the rising incidence of kidney stones. Ambulatory surgical service providers are expected to experience a surge in the treatment demand as a result of the unhealthy lifestyle changes, especially in the developed countries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Treatment type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urolithiasis Management Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Urolithiasis Management Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Urolithiasis Management Devices: Treatment Type Estimates & Trend Analysis

  • 4.1. Urolithiasis Management Devices Market: Key Takeaways
  • 4.2. Urolithiasis Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 4.3.1. Extracorporeal shock wave lithotripsy (ESWL) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Intracorporeal Lithotripsy
    • 4.4.1. Intracorporeal lithotripsy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Percutaneous Nephrolithotomy
    • 4.5.1. Percutaneous nephrolithotomy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Other Treatments
    • 4.6.1. Other treatments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Urolithiasis Management Devices: End Use Estimates & Trend Analysis

  • 5.1. Urolithiasis Management Devices Market: Key Takeaways
  • 5.2. Urolithiasis Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals & Clinics
    • 5.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers (ASCs)
    • 5.4.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Urolithiasis Management Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Urolithiasis Management Devices Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. UK
      • 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. France
      • 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. China
      • 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. India
      • 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Allengers
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Boston Scientific
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. BD
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Cook Medical
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. ConMed
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. DirexGroup
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Dornier MedTech
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Potent Optotronic
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. HealthTronics
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Karl Storz
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Lumenis
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Olympus
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Richard Wolf
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Siemens Healthcare
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives